
Caracemide
CAS No. 81424-67-1
Caracemide ( NSC-253272 )
产品货号. M26639 CAS No. 81424-67-1
Caracemide 抑制大肠杆菌的核糖核苷酸还原酶。 Caracemide 可用于抗癌研究。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1037 | 有现货 |
![]() ![]() |
10MG | ¥1482 | 有现货 |
![]() ![]() |
25MG | ¥2398 | 有现货 |
![]() ![]() |
50MG | ¥3637 | 有现货 |
![]() ![]() |
100MG | ¥5338 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Caracemide
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Caracemide 抑制大肠杆菌的核糖核苷酸还原酶。 Caracemide 可用于抗癌研究。
-
产品描述Caracemide inhibits the enzyme ribonucleotide reductase of Escherichia coli. Caracemide can be used in anticancer studies.(In Vitro):Caracemide produces severe central nervous system (CNS) toxicity because of the toxic metabolite, methylisocyanate (MIC). Caracemide inactivates R1 by covalent modification at the substrate-binding site.(In Vivo):After administration of Caracemide (6.6 mg/kg;i.p.), the mercapturic acid derivative AMCC was identified in rats urine.
-
体外实验Caracemide inactivates R1 by covalent modification at the substrate-binding site and has a toxic metabolite, methylisocyanate (MIC), in vivo.
-
体内实验The mercapturic acid derivative AMCC was identified in urine rats following administration to rats of a single i.p. dose (6.6 mg/kg) of caracemide (NSC-253272). .
-
同义词NSC-253272
-
通路Others
-
靶点Other Targets
-
受体Anti-infection| Bacterial
-
研究领域——
-
适应症——
化学信息
-
CAS Number81424-67-1
-
分子量189.171
-
分子式C6H11N3O4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (528.63 mM)
-
SMILESCNC(=O)ON(C(C)=O)C(=O)NC
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Basanti LalHiran, et al. Oxidation of 3,4,5-trimethoxybenzaldehyde by pyridinium fluorochromate in N,N-dimethyl formamide medium: A kinetic and mechanistic study. Arabian Journal of Chemistry. Volume 9, Supplement 1, September 2016, Pages S440-S445
产品手册




关联产品
-
Eliglustat hemitartr...
Eliglustat Hemitartrate 的 IC50 为 24 nM,是一种特异性、有效、口服活性的葡萄糖脑糖苷酶抑制剂。Eliglustat tartrate 显示出良好的效力,IC50 为 24 nM,并且对目标酶具有特异性。一种新型的葡萄糖神经酰胺合酶抑制剂 (Genz-112638) )并评估其在戈谢病小鼠模型(D409V/null)中的活性。 Genz-112638 的生化表征显示出良好的效力(IC(50) 约为 24nM)和针对靶酶的特异性。
-
Isolariciresinol
(+)-Isolariciresinol is extracted from Radix Isatidis and shows antioxidant and anti-inflammatory activities and can be used in studies about rheumatism.
-
Citronellyl acetate
乙酸香茅酯是一种天然产物。